Victory Capital Management Inc C4 Therapeutics, Inc. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$5.06 - $26.46 $83,029 - $434,182	-16,409 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$19.99 - $33.23 $2,418 - $4,020	-121 Reduced 0.73%	16,409 $141,000
Q4 2021 Feb 07, 2022	BUY	$29.39 - $46.86 $187,713 - $299,294	6,387 Added 62.97%	16,530 $532,000
Q3 2021 Nov 02, 2021	BUY	$35.91 - $50.5 $30,092 - $42,319	838 Added 9.01%	10,143 $453,000
Q2 2021 Aug 03, 2021	BUY	$30.39 - $42.18 $28,779 - $39,944	947 Added 11.33%	9,305 $352,000
Q1 2021 May 04, 2021	BUY	$31.96 - $46.5 $267,121 - $388,647	8,358 New	8,358 $309,000

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $208M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.